FDA Investigator Sharon L Matson

Sharon L Matson has inspections in 14 countries as of 01 Dec 2023. Sharon L Matson has collaborated with a combinined 2599 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
277
Last Inspection Date:
01 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
100002961
Country:
United States of America, Australia, Canada, Austria, Georgia, Japan, Bosnia and Herzegovina, Poland, Spain, Malaysia, Germany, Italy, Sweden
Co-Investigator(s):
A Williams, Aaron L Dunbar, Aimee J Edwin, Albert L Nguyen, Alfred P Pistorio, Alison A Nicoli, Alison A Stone, Amy L Mcintyre, Ana M Placencia, Andrea B Slavin, Annabelle Crusan, D,VM, Anthony J Ladner, April L Brown, April L Young, Benjamin J Dastoli, Benjamin W Anderson, Bili Jom Johnson, Bill Tacket, Jr, Billi Jom Johnson, Carol Mrivera Lopez, PhD, Carolyn A Warren, Charles R Cote, RIC, Cheron M Portee, Chester B Whitley, Christina L Bigham, Christine M Parmentier, Corey K Reno, Courtney R Tiegs, Craig A Garmendia, Ct Viswanathan, PhD, Cynthia F Kleppinger, MD, Dacia E Quick, Dale A Nyberg, Darren D Holaday, Demetria L Lueneburg, Denise D Dion, Denise L Burosh, Denise M Digiulio, Diane Cvan Leeuwen, Douglas W Atkins, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Elizabeth E Hart (ASCP), MT, Eric M Padgett, Eric S Myskowski, Eric T Huebler, Fannie M Harrell, Gregory A Berg, Gregory S Larson, Gregory W Smith, Harperd, Howard A Burmester, Hugh M Mcclure, II, Ivan E Reyes, Jaclyn N Munsch, James A Beaulieu, James G Beaulieu, James M Kewley, James P Mcevoy, Jan L Hewett, Jane E Nelson, Janis R Armedoriz, Jay V Jariwala, Jeanne M Morris, Jennifer Al Vollon, Jennifer Alongie Vollom, Jennifer S Ness, Jessica L Johnson, Joan T Briones, Jocelyn M Muggli, Joey C West, John E Emmert, Jonathan G Swoboda, Jonee J Mearns, Joseph D Gong, Joseph M Edwin, Jyoti B Patel, PhD, Karen M Labounty, Karen M Montgomery (KMM), Kellie L Thommes, RN, Kellie L Westerbuhr, Kevin A Swiss, PhD, Kevin P Regan, Kimberly Lewandowski Walker, Kyle J Mccracken, Laiza V Garcia, Lisa M Lopez, Lori S Lawless, M Edith Snyder, Mada A Tautges, Margaret M Annes, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Mary A Millner, Matthew B Casale, Melissa D Kalik, Melissa I Michurski, Msdap Gonzlezk, Nicole C Victoria, PhD, Nilufer Tampal, PhD, Norman Wong, Paola E Lathrop, Ralph Jerndal, Ralph W Jemdal, Rene R Ramirez, Rhonda L Mecl, Rhonda L Meel, Richard Jay Tucker, RS, Richard W Berning, Robert C Steyert, Ronald R Ruff, Ross J Grigsby, Ryan J Benedict, Sandra A Hughes, Sandra Sejdinovic, Scott A Golladay, Scott B Laufenberg, Shannon M Berg, Sharon K Thoma, PharmD, Sharon M Harold, Sripal R Mada, PhD, State Agency, Stephanie Mangigian, MS/OSH, RN, Susan A Atcher, Susan M Atcher, Susan M Matthias, Tara C Singh, Tara Singh, Timothy G Philips, Timothy R Marrs, Tony T Yang, Toyin B Oladimeji, Traci C Kelm, Tracy A Solseng, Tyler R Courtney, Wayne W Grundstrom, William E Keer, Xikui Chen (nmi), PhD, Xikui Nmi Chen, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Yoon K Oh, Yvette Mlacour Davis

Sharon L Matson's Documents

Publish Date Document Type Title
September, 2014 FDA 483 Boston Scientific Corporation - Form 483, 2014-09-17
September, 2014 EIR Patrick Flynn - EIR, 2014-09-05
March, 2019 FDA 483 Abu Dayyeh, Barham, K., MD, MPH, Clinical Investigator - Form 483, 2019-03-05
April, 2007 EIR Schrock, Christian M.D. - EIR, 2007-04-10
November, 2017 FDA 483 Matson, Mark A., MD, Clinical Investigator, Prism Research - Form 483, 2017-11-15
June, 2017 EIR Chester Whitely - EIR, 2017-06-29
March, 2002 FDA 483 Lunde, N. Martin, MD, Clinical Investigator - Form 483, 2002-03-26
December, 2001 EIR 3M Company - Health Care Business - EIR, 2001-12-06
December, 2004 EIR 3M Company - EIR, 2004-12-02
March, 2017 FDA 483 Zogg, Donald L., M.D., Clinical Investigator - Form 483, 2017-03-01
March, 2018 EIR Morie A. Gertz, M.D., Clinical Investigator - EIR, 2018-03-09
December, 2001 FDA 483 3M Center - Form 483, 2001-12-06
June, 2012 FDA 483 The Integra Group, Inc. - Form 483, 2012-06-11
October, 2019 FDA 483 Response Padagis US LLC - Form 483R, 2019-11-07
July, 2013 FDA 483 Allina Health [IRB] - Form 483, 2013-07-01
June, 2000 EIR Whitley, Chester B., Ph.D., M.D., Clinical Investigator - EIR, 2000-06-16
December, 2003 FDA 483 WuXi AppTec Inc - Form 483, 2003-12-18
April, 2000 FDA 483 [Total Renal Research, Inc./CRU] - Form 483, 2000-04-07
February, 2022 FDA 483 Samuel J. Maiser, M.D., Clinical Investigator - Form 483, 2022-02-11
October, 2019 EIR Padagis US LLC - EIR, 2019-10-23
February, 2023 FDA 483 Children's Healthcare IRB #1 - Form 483, 2023-02-03
August, 2018 FDA 483 Human Subjects Research Committee - Form 483, 2018-08-23
March, 2023 FDA 483 John C. Lieske, M.D., Clinical Investigator - Form 483, 2023-03-03
August, 2023 FDA 483 Paul Sorajja, M.D., Clinical Investigator - Form 483, 2023-08-28
November, 2000 FDA 483 St. Jude Medical - Form 483, 2000-11-21
June, 2005 EIR Medtox Laboratories, Inc. - EIR, 2005-06-28
August, 2018 FDA 483 Response Human Subjects Research Committee - Form 483R, 2018-09-14
September, 2019 FDA 483 Anthony J. Windebank, M.D., Clinical Investigator - Form 483, 2019-09-19
September, 2022 FDA 483 WuXi AppTec Inc - Form 483, 2022-09-07
June, 2002 EIR Boston Scientific Corporation - EIR, 2002-06-20
June, 2001 FDA 483 Minnesota Clinical Study Center, aka Steven E. Kempers, M.D., CI - Form 483, 2001-06-14
July, 2000 EIR Rhame, Frank S., M.D., Clinical Investigator - EIR, 2000-07-27
April, 2015 FDA 483 PAREXEL International GmbH - Form 483, 2015-04-17
July, 2013 EIR Allina Health [IRB] - EIR, 2013-07-01
June, 2010 FDA 483 Spineology, Inc. - Form 483, 2010-06-30
March, 2002 EIR Lunde, N. Martin, MD, Clinical Investigator - EIR, 2002-03-26
March, 2018 FDA 483 Response Morie A. Gertz, M.D., Clinical Investigator - Form 483R, 2018-03-22
July, 2002 FDA 483 Boston Scientific Corporation - Form 483, 2002-07-25
September, 2017 FDA 483 Boston Scientific Corporation - Form 483, 2017-09-22
June, 2007 FDA 483 Response Boston Scientific Corporation - Form 483R, 2007-05-16
July, 2000 FDA 483 [Clinic 42, Abbott Northwestern Hosp.] - Form 483, 2000-07-27
February, 2000 FDA 483 CMAX - Form 483, 2000-02-29
September, 2015 FDA 483 U Of MN Research Subjects' Protection Program/ IRB - Form 483, 2015-09-25
January, 2014 EIR Hardten, David R., MD, Clinical Investigator - EIR, 2014-01-27
April, 2000 FDA 483 Zavoral, James H., M.D., Clinical Investigator - Form 483, 2000-04-19
November, 2021 FDA 483 Boston Scientific Corporation - Form 483, 2021-11-18
March, 2018 FDA 483 Morie A. Gertz, M.D., Clinical Investigator - Form 483, 2018-03-09
March, 2022 FDA 483 HealthPartners Institute IRB - Form 483, 2022-03-14
October, 2002 EIR Henry, Keith W (M.D.) - EIR, 2002-10-28
September, 2005 EIR Medtronic Physiological Research Lab - EIR, 2005-09-29
July, 2002 EIR Boston Scientific Corporation - EIR, 2002-07-25
October, 2011 EIR U Of MN Research Subjects' Protection Program/ IRB - EIR, 2011-10-18
September, 2014 EIR Boston Scientific Corporation - EIR, 2014-09-17
February, 2000 EIR CMAX Pty., Ltd., S.A. - EIR, 2007-02-08
June, 2002 FDA 483 Boston Scientific Corporation - Form 483, 2002-06-20
June, 2001 EIR Associated Skin Care Specialists PA - EIR, 2001-06-14
August, 2012 FDA 483 Response Miner, James R., MD, Clinical Investigator - Form 483R, 2012-08-31
April, 2000 EIR Zavoral, James H., M.D., Clinical Investigator - EIR, 2000-04-19
October, 2001 FDA 483 Orphan Medical, Inc. - Form 483, 2001-01-10
October, 2001 EIR Orphan Medical, Inc. - EIR, 2001-01-09
April, 2023 FDA 483 National Marrow Donor Program IRB - Form 483, 2023-04-04
February, 2013 FDA 483 NAMSA - Form 483, 2013-02-04
November, 2018 FDA 483 Boston Scientific Corporation - Form 483, 2018-11-16
September, 2005 FDA 483 Medtronic Physiological Research Lab - Form 483, 2005-09-29
January, 2005 EIR Olson, Stephen, MD Clinical Investigator - EIR, 2005-01-26
March, 2021 FDA 483 Berman, Gary D., MD, Clinical Investigator - Form 483, 2021-03-29
March, 2005 FDA 483 Surpass, Inc. - Form 483, 2005-03-30
May, 2022 FDA 483 Kearney, Susan L., M.D., Clinical Investigator - Form 483, 2022-05-10
April, 2019 FDA 483 Lauren R. Klein, MD, MS, Sponsor-Investigator - Form 483, 2019-04-23
April, 2017 FDA 483 3M Company IRB - Form 483, 2017-04-14
June, 2007 FDA 483 Boston Scientific Corporation - Form 483, 2007-05-16
April, 2000 EIR DaVita Clinical Research - EIR, 2000-04-07
May, 2011 FDA 483 American Preclinical Services - Form 483, 2011-05-04
September, 2018 FDA 483 Henry, W. Keith, M.D., Clinical Investigator - Form 483, 2018-09-19
July, 2002 EIR Boston Scientific Corporation - EIR, 2002-07-10
October, 2002 FDA 483 HCMC - Form 483, 2002-10-28
September, 2015 EIR U Of MN Research Subjects' Protection Program/ IRB - EIR, 2015-09-25
June, 2012 EIR The Integra Group, Inc. - EIR, 2012-06-11
October, 2001 EIR Orphan Medical, Inc. - EIR, 2001-10-01
November, 2000 FDA 483 Response St. Jude Medical - Form 483R, 2000-12-01
June, 2016 EIR Chhavi Chadha, MD - EIR, 2016-06-27
August, 2012 EIR Miner, James R., MD, Clinical Investigator - EIR, 2012-08-23
February, 2021 FDA 483 Frank A. Sinicrope, M.D., Clinical Investigator - Form 483, 2021-02-26
December, 2003 EIR WuXi AppTec Inc - EIR, 2003-12-18
December, 2001 FDA 483 Response 3M Company - Health Care Business - Form 483R, 2002-02-20
August, 2011 FDA 483 Dr. Indralingam Vaithilingam - Form 483, 2011-08-25
September, 2014 FDA 483 Response Boston Scientific Corporation - Form 483R, 2014-10-06
December, 2005 FDA 483 Medtronic Heart Valve Division - Form 483, 2005-12-08
October, 2001 FDA 483 Response Orphan Medical, Inc. - Form 483R, 2001-02-06
September, 2015 FDA 483 Response U Of MN Research Subjects' Protection Program/ IRB - Form 483R, 2015-10-13
May, 2012 EIR WuXi AppTec Inc - EIR, 2012-05-01
June, 2010 EIR Spineology, Inc. - EIR, 2010-06-30
June, 2016 FDA 483 Response Chhavi Chadha, MD - Form 483R, 2016-07-13
September, 2022 EIR WuXi AppTec Inc - EIR, 2022-10-13
March, 2020 FDA 483 Syntenza Pharmaceuticals, LLC - Form 483, 2020-03-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more